نتایج جستجو برای: .erbb2

تعداد نتایج: 9064  

پایان نامه :وزارت علوم، تحقیقات و فناوری - دانشگاه فردوسی مشهد - دانشکده دامپزشکی 1393

سرطان پستان شایع¬ترین و مهم ترین بدخیمی در بین زنان در سراسر دنیا است. سلول¬های سرطانی از مسیرهای سیگنالینگ مختلف و متعدد گیرنده¬های خانواده فاکتور رشد اپیدرمال، جهت مقاومت به آنتی¬بادی-های ضد سرطانی مثل trastuzumab بهره می برند. مسیرهای سیگنالینگ همپوشان گیرنده های erbb1 و erbb2 از مهم ترین علل شکست استراتژی های درمانی در سرطان پستان می باشد. هدف از این مطالعه تولید آنتی بادی های نوترکیب انسان...

Journal: :avicenna journal of medical biotechnology 0

background: genes for human epidermal growth factor receptors b1 (erbb1) and b2 (erbb2) were amplified in breast and ovarian cancers. both of them were associated with aggressive disease and worse prognosis. the erbb1 or erbb2 status of a tumor may provide an indication of the response to erbb1 and erbb2 -targeted therapies. for accurate and rapid assessment of amplification of erbb1 and erbb2 ...

Journal: :international journal of endocrinology and metabolism 0
wei-jiang zhao center for neuroscience, shantou university medical college, shantou, people's republic of china; center for neuroscience, shantou university medical college, 22 xin ling road, shantou, guandong province 515041, people’s republic of china. tel: + 86-13794125386, fax: + 86-75488900236

background although neuregulin-1 (nrg1)and its receptors have been indicated at the mrna level in partial human endocrine organs and its functional roles have been evaluated in vitro, their morphological distribution in higher animals are not fully studied. the present research focused on expression of nrg1 and its main receptors erbb2 and erbb4 in main endocrine organs of the rhesus monkey. ma...

Journal: :Journal of Investigative Dermatology 2023

Background: Status of tumor receptor, including estrogen receptor(ER), progesterone receptor(PR) and Erb-B2 Receptor Tyrosine Kinase 2(ERBB2), is important to predict clinical behavior in breast cancer. Cutaneous metastasis from cancer a dismal sign. However, whether the receptor status would differ primary skin metastatic sites conversion affect remain unknown. Methods: From 2002 2021, 41 pati...

Journal: :Genes, chromosomes & cancer 2006
Christopher C Benz Vita Fedele Fan Xu Bauke Ylstra David Ginzinger Mamie Yu Dan Moore Rayna Kneuper Hall Daynna J Wolff Mary L Disis Serenella Eppenberger-Castori Urs Eppenberger Francesco Schittulli Stefania Tommasi Angelo Paradiso Gary K Scott Donna G Albertson

Analysis of a collection of human breast cancers (n = 150), enriched in ERBB2-positive cases (n = 57) and involving tumor genotyping relative to population-matched blood genotyping (n = 749) for a common ERBB2 single nucleotide polymorphism Ala(G)1170Pro(C), revealed that ERBB2 amplification in breast cancer is invariably monoallelic. Analysis of paired breast cancer and blood samples from info...

Journal: :Oncology reports 2010
Xiaohua Liu Yincheng Zhang Wenhao Ren Guozhou Rao

erbB2 gene plays an important role in carcinoma formation. erbB2 overexpression was observed in many types of tumours, including salivary carcinoma. However, a putative erbB2 and PTEN interaction remains largely unknown in salivary adenoid cystic carcinoma cells. The purpose of this study was to silence erbB2 gene and investigate the functional relationship between erbB2 and PTEN in SACC-83 sal...

Journal: :Molecular cancer research : MCR 2013
Amanda K Paulson Erik S Linklater Bree D Berghuis Colleen A App Leon D Oostendorp Jayne E Paulson Jane E Pettinga Marianne K Melnik George F Vande Woude Carrie R Graveel

UNLABELLED Breast cancer displays significant intratumoral heterogeneity, which has been shown to have a substantial impact on both innate and acquired resistance to tyrosine kinase inhibitors. The heterogeneous expression of multiple receptor tyrosine kinases (RTK) in cancers supports tumor signaling robustness and plays a significant role in resistance to targeted inhibition. Recent studies h...

Journal: :Molecular cancer therapeutics 2011
Wenle Xia Zuguo Liu Rongrong Zong Leihua Liu Sumin Zhao Sarah S Bacus Yubin Mao Jia He Julia D Wulfkuhle Emanuel F Petricoin Takuya Osada Xiao-Yi Yang Zachary C Hartman Timothy M Clay Kimberly L Blackwell Herbert K Lyerly Neil L Spector

ErbB2 tyrosine kinase inhibitors (TKI) block tyrosine autophosphorylation and activation of the full-length transmembrane ErbB2 receptor (p185(ErbB2)). In addition to p185(ErbB2), truncated forms of ErbB2 exist in breast cancer cell lines and clinical tumors. The contribution of these truncated forms, specifically those expressed in tumor cell nuclei, to the development of therapeutic resistanc...

ژورنال: بیماری های پستان 2022
, , Forouzesh, Flora , Javidi, Mohammad Amin, Majid Ansari, Alireza, Mehdizadeh, Romina , Sanati, Hassan , Shayeghan, Mohadeseh ,

Introduction: Breast cancer is the most common cancer and the first cause of cancer-related death in women worldwide. Although admirable achievements have been made in finding new therapeutic interventions, introducing efficient approaches with the least side effect is still undoubtedly demanded. Exposure to extremely-low frequency electromagnetic field (ELF-EMF) with specific parameters of fre...

Journal: :Carcinogenesis 2013
Malgorzata Magdalena Sak Monika Szymanska Vibeke Bertelsen Max Hasmann Inger Helene Madshus Espen Stang

Overexpression of ErbB2 and ErbB3 is found in several human cancers, and ErbB2-ErbB3 heterodimers are known as the most potent signaling units among ErbB dimers. While ErbB2 probably undergoes weak endocytosis, ErbB3 is readily internalized even in the absence of added ligand and without requirement for kinase activity. Overexpression of ErbB2 has been demonstrated to inhibit epidermal growth f...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید